Backstrm and colleagues, after a 5-year follow-up, found that initial plasma NfL levels in PD-MCI patients were higher than in PD patients without cognitive impairment, and NfL for each increase of 10pg/mL, the risk of dementia conversion increased 2.3-fold (39). The gene discussed is NEFL; the disease is Cognitive impairment.